Sequential Multiple Assignment Randomized Trial to Treat Urinary Symptoms in Parkinson Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07187466

Title field or adapter rule

{'original_value': 'Sequential Multiple Assignment Randomized Trial to Treat Urinary Symptoms in Parkinson Disease', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:33.561534+00:00

Published At

2026-10-27T00:00:00+00:00

Record Updated At

2026-10-27

Source Retrieved At

2026-10-31T22:18:37.902788+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Overactive Bladder", "Parkinson Disease"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-27", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07187466"

protocolSection.identificationModule.officialTitle

"Sequential Multiple Assignment Randomized Trial to Treat Urinary Symptoms in Parkinson Disease"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["PHASE4"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Overactive Bladder (protocolSection.conditionsModule.conditions)
• Parkinson Disease (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Combined Drug and Behavioral Therapy Group', 'Drug Therapy Group'], 'description': 'Mirabegron is a beta-3-agonist, which acts upon the noradrenergic system and avoids the cognitive and gastrointestinal side effects of anticholinergic bladder relaxants.', 'name': 'mirabegron', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Behavioral Therapy Group', 'Combined Drug and Behavioral Therapy Group'], 'description': 'The exercise-based behavioral therapy is a comprehensive training program administered individually by a trained nurse practitioner interventionist to address urinary incontinence and other lower urinary tract symptoms.', 'name': 'Exercise-based behavioral therapy', 'type': 'BEHAVIORAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• mirabegron (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.